MetLife Inc. [NYSE: MET] price surged by 3.18 percent to reach at $2.03. The company report on August 10, 2022 that MetLife Sponsors UC Cleantech Accelerator Program.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
MetLife and Haas School of Business, University of California, Berkeley, today announced that MetLife has sponsored the Cleantech to Market (C2M) accelerator program. MetLife is providing financial support for the school’s 2022 C2M program, which creates and coaches interdisciplinary teams of Berkeley graduate students to assist entrepreneurs from across the country in commercializing the most promising climate tech innovations. MetLife will also award Climate Solution prizes to the top three teams during C2M’s Annual Climate Tech Summit in early December. The monetary prizes will support the growth of the winning teams’ solutions.
In addition, MetLife employees will lend business development and management expertise to the C2M program by serving as guest speakers, mentors, and coaches throughout the semester, while also learning about cutting-edge clean technology solutions.
A sum of 4217673 shares traded at recent session while its average daily volume was at 4.59M shares. MetLife Inc. shares reached a high of $65.98 and dropped to a low of $64.64 until finishing in the latest session at $65.93.
The one-year MET stock forecast points to a potential upside of 13.1. The average equity rating for MET stock is currently 1.70, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on MetLife Inc. [MET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $75.87 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for MetLife Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 23, 2022. While these analysts kept the previous recommendation, Citigroup raised their target price to Buy. The new note on the price target was released on May 24, 2022, representing the official price target for MetLife Inc. stock. Previously, the target price had yet another raise to $74, while Jefferies analysts kept a Buy rating on MET stock.
The Average True Range (ATR) for MetLife Inc. is set at 1.53, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.79. The Price to Book ratio for the last quarter was 1.01, with the Price to Cash per share for the same quarter was set at 28.66. Price to Free Cash Flow for MET in the course of the last twelve months was 4.94.
MET Stock Performance Analysis:
MetLife Inc. [MET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.66. With this latest performance, MET shares gained by 6.70% in over the last four-week period, additionally sinking by -6.26% over the last 6 months – not to mention a rise of 6.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 64.24, with the RSI for the last a single of trading hit 71.20, and the three-weeks RSI is set at 59.29 for MetLife Inc. [MET]. The present Moving Average for the last 50 days of trading for this stock 62.90, while it was recorded at 63.97 for the last single week of trading, and 65.06 for the last 200 days.
Insight into MetLife Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and MetLife Inc. [MET] shares currently have an operating margin of +10.97. MetLife Inc.’s Net Margin is presently recorded at +9.41.
Return on Equity for this stock inclined to 9.23, with Return on Assets sitting at 0.84.
MET Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MetLife Inc. go to -0.70%.
MetLife Inc. [MET] Insider Position Details
There are presently around $39,824 million, or 76.10% of MET stock, in the hands of institutional investors. The top three institutional holders of MET stocks are: BLACKROCK INC. with ownership of 70,186,350, which is approximately -2.092% of the company’s market cap and around 0.20% of the total institutional ownership; DODGE & COX, holding 58,433,230 shares of the stock with an approximate value of $3.85 billion in MET stocks shares; and VANGUARD GROUP INC, currently with $3.77 billion in MET stock with ownership of nearly 0.528% of the company’s market capitalization.
Positions in MetLife Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 605 institutional holders increased their position in MetLife Inc. [NYSE:MET] by around 34,703,016 shares. Additionally, 510 investors decreased positions by around 43,267,599 shares, while 202 investors held positions by with 526,069,006 shares. The mentioned changes placed institutional holdings at 604,039,621 shares, according to the latest SEC report filing. MET stock had 108 new institutional investments in for a total of 4,665,049 shares, while 102 institutional investors sold positions of 4,114,348 shares during the same period.